Pm. Grasby et al., THE EFFECT OF THE DOPAMINE AGONIST, APOMORPHINE, ON REGIONAL CEREBRALBLOOD-FLOW IN NORMAL VOLUNTEERS, Psychological medicine, 23(3), 1993, pp. 605
Apomorphine, a non-selective dopamine agonist, has been used as a phar
macological probe for investigating central dopaminergic neurotransmis
sion in psychiatric illness. In this study repeated measurements of re
gional cerebral blood flow (rCBF) were made in normal volunteers befor
e, and after, the administration of apomorphine (5 or 10 mug/kg), or p
lacebo. The difference in rCBF, before and after drug (apomorphine ver
sus placebo), was used to identify brain areas affected by apomorphine
. Compared to placebo, both doses of apomorphine increased blood flow
in the anterior cingulate cortex. Apomorphine 10 mug/kg also increased
prefrontal rCBF (right > left). No decreases in rCBF were noted follo
wing either dose of apomorphine. Apomorphine-induced increases of ante
rior cingulate blood flow might serve as an in vivo index of central d
opamine function. Such an approach would complement established neuroe
ndocrine challenge paradigms for investigating central dopamine neurot
ransmission in psychiatric illness.